Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, T-Cell, Peripheral 2Lymphoma, Large B-Cell, Diffuse 2Breast Neoplasms 2Urologic Diseases 1Taste Disorders 1Renal Insufficiency 1Recurrence 1Malnutrition 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Kidney Neoplasms 1Kidney Diseases 1Intracranial Germ Cell Tumors 1Hypothermia 1Carcinoma, Renal Cell 1

Interventions

aldesleukin 42Sunitinib 39Cyclophosphamide 30Nivolumab 27Everolimus 27pembrolizumab 26Interferon-alpha 25Bevacizumab 22Sorafenib 21Interleukin-2 20fludarabine phosphate 19Filgrastim 18Ipilimumab 17Radiotherapy 16Axitinib 16Peripheral Blood Stem Cell Transplantation 15Gemcitabine 15cabozantinib 14fludarabine 11Radiosurgery 11Doxorubicin 11Carboplatin 11temsirolimus 10Etoposide 9Chemotherapy, Adjuvant 9sargramostim 8belzutifan 8atezolizumab 8Fluorouracil 8pazopanib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Kidney Neoplasms × Ice × Clear all
NCT01529658 2016-10-27

Renal Hypothermia During Partial Nephrectomy

Ottawa Hospital Research Institute

Phase NA Unknown
184 enrolled
Genitourinary

Carcinoma, Renal Cell, Hypothermia, Kidney Diseases, Kidney Neoplasms, Neoplasms, Urologic Diseases, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡